SummaryAtypical hemolytic uremic syndrome (HUS) presents with the clinical features of hypertension, microangiopathic hemolytic anemia, and acute renal failure. Both dominant and recessive modes of inheritance have been reported. This study describes the genetic and functional analysis of a large Bedouin kindred with autosomal recessive HUS. The kindred consists of several related nuclear families in which all parent unions of affected children are consanguineous. A previous report demonstrated that a dominant form of HUS maps to chromosome 1q and that complement factor H (CFH), a regulatory component of the complement system, lies within the region and is involved in the dominant disorder. Early-onset and persistent hypocomplementemia in t...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Mutations and polymorphisms in the gene-encoding factor H (CFH) are associated with atypical hemolyt...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
SummaryAtypical hemolytic uremic syndrome (HUS) presents with the clinical features of hypertension,...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Hemolytic uremic syndrome (HU...
Atypical hemolytic uremic syndrome (aHUS) is a severe renal disease that is associated with defectiv...
Hemolytic-uremic syndrome (HUS) is a microvasculature disorder leading to microangiopathic hemolytic...
Background Sequence analysis of the regulators of complement activation (RCA) cluster of genes at ch...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Communicated by Mark H. Paalman Many of the complement regulatory genes within the RCA cluster (1q32...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
Atypical haemolytic uraemic syndrome is causedby alternative complement pathway dysregulation. It ha...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Mutations and polymorphisms in the gene-encoding factor H (CFH) are associated with atypical hemolyt...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...
SummaryAtypical hemolytic uremic syndrome (HUS) presents with the clinical features of hypertension,...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Atypical hemolytic uremic syndrome (aHUS) is associated with mutations in the gene CFH encoding the ...
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Hemolytic uremic syndrome (HU...
Atypical hemolytic uremic syndrome (aHUS) is a severe renal disease that is associated with defectiv...
Hemolytic-uremic syndrome (HUS) is a microvasculature disorder leading to microangiopathic hemolytic...
Background Sequence analysis of the regulators of complement activation (RCA) cluster of genes at ch...
Atypical hemolytic uremic syndrome (aHUS) is associated with complement alternative pathway defects ...
Communicated by Mark H. Paalman Many of the complement regulatory genes within the RCA cluster (1q32...
BACKGROUND: Atypical HUS (aHUS) is thought to be caused by predisposing mutations in genes encoding ...
Atypical haemolytic uraemic syndrome is causedby alternative complement pathway dysregulation. It ha...
Genetic studies have demonstrated the involvement of the complement regulator factor H in nondiarrhe...
Mutations and polymorphisms in the gene-encoding factor H (CFH) are associated with atypical hemolyt...
Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) disorder characterised by the ...